Drug Testing Clinical Payment and Coding Policy
Blue Cross and Blue Shield of Texas (BCBSTX) has updated the Clinical Payment and Coding Policies page to include an update to the Drug Testing Clinical Payment and Coding Policy effective 05/01/2020. Changes to this policy are based on compliance with the United States Preventive Services Task Force updates.
Clinical Payment and Coding Policies are based on criteria developed by specialized professional societies, national guidelines (e.g., MCGTM) and the Centers for Medicare & Medicaid Services (CMS) Provider Reimbursement Manual. Additional sources are used and can be provided upon request. The clinical payment and coding guidelines are not intended to provide billing or coding advice but to serve as a reference for facilities and providers.
If you have any questions or if you need additional information, please contact your BCBSTX Network Management Representative.